双抗-话题@MedSci

#双抗#

81篇内容 | 3540人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1487248, encodeId=6c83148e2482a, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=欧洲心脏杂志研究称：未放支架的心梗患者，或应长期双抗治疗, objectType=article, longId=184825, objectId=08a018482500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08a018482500, replyNumber=0, likeNumber=75, createdTime=2019-12-17, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08a018482500, moduleTitle=欧洲心脏杂志研究称：未放支架的心梗患者，或应长期双抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08a018482500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487247, encodeId=3aff148e247e8, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=宜明昂科CD20/CD47双抗药物获批进入临床, objectType=article, longId=183838, objectId=4ac7183838c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ac7183838c5, replyNumber=0, likeNumber=97, createdTime=2019-12-01, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ac7183838c5, moduleTitle=宜明昂科CD20/CD47双抗药物获批进入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ac7183838c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487246, encodeId=fa32148e246e0, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Circulation：不同的双抗持续时间具有不同的临床意义, objectType=article, longId=175654, objectId=c1231e565464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1231e565464, replyNumber=0, likeNumber=66, createdTime=2019-07-18, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1231e565464, moduleTitle=Circulation：不同的双抗持续时间具有不同的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1231e565464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487245, encodeId=de24148e2451f, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%, objectType=article, longId=175408, objectId=68c91e54082a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c91e54082a, replyNumber=0, likeNumber=34, createdTime=2019-07-15, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c91e54082a, moduleTitle=BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c91e54082a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487244, encodeId=6ab1148e2445b, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Stroke：真实世界中双抗对大动脉粥样硬化性卒中的疗效, objectType=article, longId=174973, objectId=23fb1e497378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23fb1e497378, replyNumber=0, likeNumber=70, createdTime=2019-07-08, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23fb1e497378, moduleTitle=Stroke：真实世界中双抗对大动脉粥样硬化性卒中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23fb1e497378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487243, encodeId=bcd8148e24399, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗, objectType=article, longId=174665, objectId=925a1e466513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925a1e466513, replyNumber=0, likeNumber=61, createdTime=2019-07-03, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925a1e466513, moduleTitle=BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925a1e466513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487242, encodeId=262e148e24225, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=JAMA：PCI后1个月强化双抗血小板治疗的效果优于传统12个月疗法, objectType=article, longId=173296, objectId=0dd41e32968f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dd41e32968f, replyNumber=0, likeNumber=66, createdTime=2019-06-28, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dd41e32968f, moduleTitle=JAMA：PCI后1个月强化双抗血小板治疗的效果优于传统12个月疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dd41e32968f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487241, encodeId=34db148e241bd, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性, objectType=article, longId=163379, objectId=b3551633e90f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3551633e90f, replyNumber=0, likeNumber=88, createdTime=2019-04-02, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3551633e90f, moduleTitle=寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3551633e90f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487240, encodeId=575f148e24066, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=第十七届中国介入心脏病学大会（CIT2019)|寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性, objectType=article, longId=163378, objectId=adba1633e8c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adba1633e8c7, replyNumber=0, likeNumber=41, createdTime=2019-04-02, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adba1633e8c7, moduleTitle=第十七届中国介入心脏病学大会（CIT2019)|寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adba1633e8c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487239, encodeId=bced148e2398d, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗, objectType=article, longId=162433, objectId=a15f162433cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a15f162433cb, replyNumber=0, likeNumber=38, createdTime=2019-03-17, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a15f162433cb, moduleTitle=2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a15f162433cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487238, encodeId=03c5148e23859, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=2018 临床实践指南：急性高危短暂性脑缺血发作和轻型缺血性卒中应用阿司匹林和氯吡格雷进行双抗治疗, objectType=article, longId=159577, objectId=0b221595e783, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b221595e783, replyNumber=0, likeNumber=57, createdTime=2019-02-08, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b221595e783, moduleTitle=2018 临床实践指南：急性高危短暂性脑缺血发作和轻型缺血性卒中应用阿司匹林和氯吡格雷进行双抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b221595e783)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487237, encodeId=b239148e237e8, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=药明生物与安科生物针对抗肿瘤双抗开发签署合作框架协议, objectType=article, longId=156680, objectId=f4ad15668034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ad15668034, replyNumber=0, likeNumber=101, createdTime=2018-12-27, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ad15668034, moduleTitle=药明生物与安科生物针对抗肿瘤双抗开发签署合作框架协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4ad15668034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487236, encodeId=3295148e23665, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=药明生物4.5亿美元授权英国OBT公司使用WuXiBody(TM)开发五个双抗, objectType=article, longId=155629, objectId=68391556298a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68391556298a, replyNumber=0, likeNumber=76, createdTime=2018-12-13, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68391556298a, moduleTitle=药明生物4.5亿美元授权英国OBT公司使用WuXiBody(TM)开发五个双抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68391556298a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487235, encodeId=89eb148e2359a, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=药明生物与ABL Bio针对多个双抗达成**开发与生产战略合作, objectType=article, longId=154626, objectId=89d415462606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d415462606, replyNumber=0, likeNumber=84, createdTime=2018-12-01, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d415462606, moduleTitle=药明生物与ABL Bio针对多个双抗达成**开发与生产战略合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d415462606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487234, encodeId=cdea148e234fe, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=J Endod：应用于牙髓再生中的不同阻射双抗糊剂的阻射性及抗菌性评估, objectType=article, longId=147070, objectId=31f014e070b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31f014e070b3, replyNumber=0, likeNumber=58, createdTime=2018-08-22, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31f014e070b3, moduleTitle=J Endod：应用于牙髓再生中的不同阻射双抗糊剂的阻射性及抗菌性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31f014e070b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487233, encodeId=902d148e23322, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=JAMA Neurol：只有多发急性梗死者才能从双抗治疗中获益？, objectType=article, longId=144256, objectId=07ba14425651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07ba14425651, replyNumber=0, likeNumber=76, createdTime=2018-07-14, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07ba14425651, moduleTitle=JAMA Neurol：只有多发急性梗死者才能从双抗治疗中获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07ba14425651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487232, encodeId=e6fd148e2325b, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=JAMA Neurol：这种梗死患者，双抗治疗更有效, objectType=article, longId=135231, objectId=8454135231c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8454135231c2, replyNumber=0, likeNumber=98, createdTime=2018-04-15, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8454135231c2, moduleTitle=JAMA Neurol：这种梗死患者，双抗治疗更有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8454135231c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487231, encodeId=a721148e23196, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=ACC2018：支架术后6个月就停用双抗治疗有危险！, objectType=article, longId=132750, objectId=8464132e506c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8464132e506c, replyNumber=0, likeNumber=76, createdTime=2018-03-19, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8464132e506c, moduleTitle=ACC2018：支架术后6个月就停用双抗治疗有危险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8464132e506c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487230, encodeId=43e5148e23058, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加, objectType=article, longId=132280, objectId=c43c13228055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43c13228055, replyNumber=0, likeNumber=94, createdTime=2018-03-15, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43c13228055, moduleTitle=Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43c13228055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1487229, encodeId=a09c148e22993, content=<a href='/topic/show?id=334b3e46139' target=_blank style='color:#2F92EE;'>#双抗#</a>, objectTitle=Lancet：老年患者PCI后缩短双抗疗程：裸金属支架vs药物洗脱支架, objectType=article, longId=128423, objectId=b860128423f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b860128423f8, replyNumber=0, likeNumber=50, createdTime=2018-02-02, rootId=0, userName=yeye5224615, userId=bbaa8296156, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b860128423f8, moduleTitle=Lancet：老年患者PCI后缩短双抗疗程：裸金属支架vs药物洗脱支架, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b860128423f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

双抗

2020-05-29

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

欧洲心脏杂志研究称：未放支架的心梗患者，或应长期双抗治疗

2019-12-17

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

宜明昂科CD20/CD47双抗药物获批进入临床

2019-12-01

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Circulation：不同的双抗持续时间具有不同的临床意义

2019-07-18

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

BMJ：药物洗脱支架术后，6月双联抗血小板理想，>12月双抗大出血风险增加78%

2019-07-15

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Stroke：真实世界中双抗对大动脉粥样硬化性卒中的疗效

2019-07-08

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

BMJ：药物洗脱支架及经皮冠状动脉介入治疗患者术后应选择短期双抗血小板治疗

2019-07-03

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

JAMA：PCI后1个月强化双抗血小板治疗的效果优于传统12个月疗法

2019-06-28

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性

2019-04-02

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

第十七届中国介入心脏病学大会（CIT2019)|寿锡凌：ACS合并高出血风险患者PCI术后双抗的复杂性

2019-04-02

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

2019 专家建议：延长亚洲急性冠脉综合征患者双抗治疗

2019-03-17

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

2018 临床实践指南：急性高危短暂性脑缺血发作和轻型缺血性卒中应用阿司匹林和氯吡格雷进行双抗治疗

2019-02-08

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

药明生物与安科生物针对抗肿瘤双抗开发签署合作框架协议

2018-12-27

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

药明生物4.5亿美元授权英国OBT公司使用WuXiBody(TM)开发五个双抗

2018-12-13

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

药明生物与ABL Bio针对多个双抗达成**开发与生产战略合作

2018-12-01

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

J Endod：应用于牙髓再生中的不同阻射双抗糊剂的阻射性及抗菌性评估

2018-08-22

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

JAMA Neurol：只有多发急性梗死者才能从双抗治疗中获益？

2018-07-14

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

JAMA Neurol：这种梗死患者，双抗治疗更有效

2018-04-15

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

ACC2018：支架术后6个月就停用双抗治疗有危险！

2018-03-19

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Lancet：双抗血小板治疗缩短至6个月导致PCI患者心肌梗死风险增加

2018-03-15

yeye5224615 (审核中...)

前往app查看评论内容

#双抗#

Lancet：老年患者PCI后缩短双抗疗程：裸金属支架vs药物洗脱支架

2018-02-02

科室
- - 订阅+
  - 更多科室
工具
服务